3-(4-AMINOPHENYL) THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY
This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment of obesity, diabetes, depression, and/or anxi...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HYMAN, CLIFTON, E BARVIAN, KEVIN, K HANDLON, ANTHONY, L HERTZOG, DONALD, L |
| description | This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment of obesity, diabetes, depression, and/or anxiety. Compounds of the invention have the formula:
L'invention concerne des nouvelles arylamines qui sont des antagonistes du récepteur de l'hormone de concentration de la mélanine 1 (MCH R1), des compositions pharmaceutiques les contenant, des procédés pour leur préparation, et leur utilisation dans des médicaments destinés à traiter l'obésité, le diabète, la dépression et/ou l'anxiété. Les composés de l'invention sont représentés par la formule (I). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005042541A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005042541A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005042541A13</originalsourceid><addsrcrecordid>eNqNi0EKwjAQRbtxIeodBtwoGGhteoC0ndoBm5RkqHZVisSVaKGewXObhQdw8fn_wX_L6JOKnRSqIW3aGnV_3gPXhIF6Sw2VQgqjEUq01CmmDh0oB01Rg01AaVYno8mxg8rYYCKwRcUNagZTgcnREfcHKEnlyOjCwtaic2R00MuQKyH362hxHx-z3_x6FW0r5KIWfnoNfp7Gm3_693AxxzjOYnnMZKKS9L_XF1qIPhA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-(4-AMINOPHENYL) THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY</title><source>esp@cenet</source><creator>HYMAN, CLIFTON, E ; BARVIAN, KEVIN, K ; HANDLON, ANTHONY, L ; HERTZOG, DONALD, L</creator><creatorcontrib>HYMAN, CLIFTON, E ; BARVIAN, KEVIN, K ; HANDLON, ANTHONY, L ; HERTZOG, DONALD, L</creatorcontrib><description>This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment of obesity, diabetes, depression, and/or anxiety. Compounds of the invention have the formula:
L'invention concerne des nouvelles arylamines qui sont des antagonistes du récepteur de l'hormone de concentration de la mélanine 1 (MCH R1), des compositions pharmaceutiques les contenant, des procédés pour leur préparation, et leur utilisation dans des médicaments destinés à traiter l'obésité, le diabète, la dépression et/ou l'anxiété. Les composés de l'invention sont représentés par la formule (I).</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050512&DB=EPODOC&CC=WO&NR=2005042541A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050512&DB=EPODOC&CC=WO&NR=2005042541A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HYMAN, CLIFTON, E</creatorcontrib><creatorcontrib>BARVIAN, KEVIN, K</creatorcontrib><creatorcontrib>HANDLON, ANTHONY, L</creatorcontrib><creatorcontrib>HERTZOG, DONALD, L</creatorcontrib><title>3-(4-AMINOPHENYL) THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY</title><description>This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment of obesity, diabetes, depression, and/or anxiety. Compounds of the invention have the formula:
L'invention concerne des nouvelles arylamines qui sont des antagonistes du récepteur de l'hormone de concentration de la mélanine 1 (MCH R1), des compositions pharmaceutiques les contenant, des procédés pour leur préparation, et leur utilisation dans des médicaments destinés à traiter l'obésité, le diabète, la dépression et/ou l'anxiété. Les composés de l'invention sont représentés par la formule (I).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAQRbtxIeodBtwoGGhteoC0ndoBm5RkqHZVisSVaKGewXObhQdw8fn_wX_L6JOKnRSqIW3aGnV_3gPXhIF6Sw2VQgqjEUq01CmmDh0oB01Rg01AaVYno8mxg8rYYCKwRcUNagZTgcnREfcHKEnlyOjCwtaic2R00MuQKyH362hxHx-z3_x6FW0r5KIWfnoNfp7Gm3_693AxxzjOYnnMZKKS9L_XF1qIPhA</recordid><startdate>20050512</startdate><enddate>20050512</enddate><creator>HYMAN, CLIFTON, E</creator><creator>BARVIAN, KEVIN, K</creator><creator>HANDLON, ANTHONY, L</creator><creator>HERTZOG, DONALD, L</creator><scope>EVB</scope></search><sort><creationdate>20050512</creationdate><title>3-(4-AMINOPHENYL) THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY</title><author>HYMAN, CLIFTON, E ; BARVIAN, KEVIN, K ; HANDLON, ANTHONY, L ; HERTZOG, DONALD, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005042541A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HYMAN, CLIFTON, E</creatorcontrib><creatorcontrib>BARVIAN, KEVIN, K</creatorcontrib><creatorcontrib>HANDLON, ANTHONY, L</creatorcontrib><creatorcontrib>HERTZOG, DONALD, L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HYMAN, CLIFTON, E</au><au>BARVIAN, KEVIN, K</au><au>HANDLON, ANTHONY, L</au><au>HERTZOG, DONALD, L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-(4-AMINOPHENYL) THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY</title><date>2005-05-12</date><risdate>2005</risdate><abstract>This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment of obesity, diabetes, depression, and/or anxiety. Compounds of the invention have the formula:
L'invention concerne des nouvelles arylamines qui sont des antagonistes du récepteur de l'hormone de concentration de la mélanine 1 (MCH R1), des compositions pharmaceutiques les contenant, des procédés pour leur préparation, et leur utilisation dans des médicaments destinés à traiter l'obésité, le diabète, la dépression et/ou l'anxiété. Les composés de l'invention sont représentés par la formule (I).</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2005042541A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | 3-(4-AMINOPHENYL) THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A35%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HYMAN,%20CLIFTON,%20E&rft.date=2005-05-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005042541A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |